Radovanovic Dragana, Seifert Burkhardt, Roffi Marco, Urban Philip, Rickli Hans, Pedrazzini Giovanni, Erne Paul
AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Department of Biostatistics, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Open Heart. 2017 Nov 14;4(2):e000689. doi: 10.1136/openhrt-2017-000689. eCollection 2017.
To assess temporal trends of in-hospital mortality in patients with acute myocardial infarction (AMI) enrolled in the Swiss nationwide registry (AMIS Plus) over the last 20 years with regard to gender, age and in-hospital treatment.
All patients with AMI from 1997 to 2016 were stratified according to ST-segment elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI), and gender using logistic regression analyses.
Among 51 725 patients, 30 398 (59%) had STEMI and 21 327 (41%) had NSTEMI; 73% were men (63.9±12.8 years) and 27% were women (71.7±12.5 years). Over 20 years, crude in-hospital STEMI mortality decreased from 9.8% to 5.5% in men and from 18.3% to 6.9% in women. In patients with NSTEMI, it decreased from 7.1% to 2.1% in men and from 11.0% to 3.6% in women. After adjustment for age, mortality decreased per additional admission year by 3% in men with STEMI (OR 0.97, 95% CI 0.96 to 0.98, P<0.001), by 5% in women with STEMI (OR 0.95, 95% CI 0.93 to 0.96, P<0.001), by 6% in men with NSTEMI (OR 0.94, 95% CI 0.93 to 0.96, P<0.001) and by 5% in women with NSTEMI (OR 0.95, 95% CI 0.93 to 0.97, P<0.001). In patients <60 years, a decrease in mortality was seen in women with STEMI (OR 0.94, 95% CI 0.90 to 0.99, P=0.025) and NSTEMI (OR 0.87, 95% CI 0.80 to 0.94, P<0.001) but not in men with STEMI (OR 1.01, 95% CI 0.98 to 1.04, P=0.46) and NSTEMI (OR 0.98, 95% CI 0.94 to 1.03, P=0.41). The mortality decrease in patients with AMI was closely associated with the increase in reperfusion therapy.
From 1997 to 2016, in-hospital mortality of patients with AMI in Switzerland has halved and was more pronounced in women, particularly in the age category <60 years.
NCT01305785; Results.
评估过去20年中纳入瑞士全国性登记处(AMIS Plus)的急性心肌梗死(AMI)患者的院内死亡率随时间的变化趋势,涉及性别、年龄和院内治疗情况。
对1997年至2016年的所有AMI患者,根据ST段抬高型心肌梗死(STEMI)或非ST段抬高型心肌梗死(NSTEMI)以及性别进行分层,采用逻辑回归分析。
在51725例患者中,30398例(59%)为STEMI,21327例(41%)为NSTEMI;73%为男性(63.9±12.8岁),27%为女性(71.7±12.5岁)。20年间,STEMI患者的男性院内粗死亡率从9.8%降至5.5%,女性从18.3%降至6.9%。NSTEMI患者中,男性从7.1%降至2.1%,女性从11.0%降至3.6%。校正年龄后,STEMI男性患者每增加一年入院,死亡率下降3%(比值比[OR]0.97,95%置信区间[CI]0.96至0.98,P<0.001),STEMI女性患者下降5%(OR 0.95,95%CI 0.93至0.96,P<0.001),NSTEMI男性患者下降6%(OR 0.94,95%CI 0.93至0.96,P<0.001),NSTEMI女性患者下降5%(OR 0.95,95%CI 0.93至0.97,P<0.001)。在<60岁的患者中,STEMI女性患者(OR 0.94,95%CI 0.90至0.99,P=0.025)和NSTEMI女性患者(OR 0.87,95%CI 0.80至0.94,P<0.001)的死亡率下降,而STEMI男性患者(OR 1.01,95%CI 0.98至1.04)和NSTEMI男性患者(OR 0.98,95%CI 0.94至1.03,P=0.41)未下降。AMI患者死亡率的下降与再灌注治疗的增加密切相关。
1997年至2016年,瑞士AMI患者的院内死亡率减半,并在女性中更为明显,尤其是在<60岁年龄组。
NCT01305785;结果